QIAGEN
Edit

QIAGEN

http://www.qiagen.com/
Last activity: 28.08.2026
Active
Categories: BioTechBuildingContentDataDiagnosticsHealthTechLifePagePersonalProvider
Links to websites are provided for convenience and do not imply sponsorship, affiliation or endorsement.


Guidelines when using our Facebook page

We ask that you please adhere to the following guidelines when using our Facebook page:

1. Netiquette

Posting and commenting on our Facebook page should follow these general communications rules:

• Treating all other users as you would like to be treated by them
• Respecting the opinions of others and not trying to force your opinion on anyone else. Everyone has the right to express their own opinion
• Respecting the rights of others

2. Deletion of posts/comments and blocking Facebook accounts

The following actions are examples that are seen as violations of the terms of use. These actions will result in the immediate deletion of posts/comments or, in the case of gross or repeated violations, we will block the user so that he or she is not able to post further content or comments on our page:

• Personal insults or degrading comments of any kind
• Defamatory, anti-constitutional, racist, or pornographic statements or illustrations
• Disparaging comments about institutions, organizations or companies, sexist or racist comments, or hate propaganda
• Any violation of the rights of third parties, in particular copyrights
• Comments that do not relate to the messages under discussion or that are off-topic
• Attacking others or calling for violence of any kind
• Calls to join in demonstrations or rallies of any political orientation
• Offering goods or services, of either a commercial or private nature, or using this Facebook page as an advertising space
• Spam, i.e., any form of automatically generated content or repeatedly posting the same comment

3. Privacy policy

We created this Facebook page in order to connect and facilitate with interested people an exchange about science, biotechnology, healthcare, molecular diagnostics, and other QIAGEN-related topics. The Privacy Policy covers how we handle personal data, which is submitted to Facebook by clicking the “Like” button on our Facebook page. This data is also accessible to QIAGEN. The data we receive from Facebook contains:

• Age demographics
• Place of residence (country and city)
• Gender
• Language
• Activity statistics/rate of all people using our page

Facebook provides this data exclusively in a summarized form. QIAGEN does not receive data on individuals or small user groups. We don’t share the data with third parties. User data is used exclusively to administer our Facebook page and to learn more about which topics are of interest to our followers so that we can further improve our page’s offering.

4. Disclaimer

The messages posted in response to our articles reflect the opinions of individual members only. We are not liable for the content of any messages, or for conclusions that may be drawn from such messages. QIAGEN makes no representations or warranties of any kind about the accuracy or completeness of the content.
Likes
52.29K
Followers
170.05K
Website visits
598.9K /mo.
Mentions
111
Location: Germany, North Rhine-Westphalia, Hilden
Employees: 5001-10000
Phone: +49 2103 290
Total raised: $100M
Founded date: 1984

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
12.07.2021-$100M-

Mentions in press and media 111

DateTitleDescription
28.08.2026Breast Cancer Liquid Biopsy Market Trends: Precision Oncology and Minimally Invasive Diagnostics Driving GrowthThe breast cancer liquid biopsy market is emerging as a promising segment of precision oncology as healthcare providers increasingly seek minimally invasive approaches for cancer detection, monitoring, and treatment planning. Liquid biopsy ...
27.08.2026Preimplantation Genetic Diagnosis Market to Reach USD 1,135.0 Million by 2030The global Preimplantation Genetic Diagnosis Market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, registering a CAGR of 10.5% during the forecast period. Market growth is being driven by the increasing ...
21.08.2026Pixelgen Technologies Raises $15.5 Million Series B To Scale Molecular Cell Architecture Platform GloballyPixelgen Technologies has closed an oversubscribed $15.5 million Series B financing to accelerate global commercialization of its Proxiome Kit and expand the company’s presence in key markets. Flat Capital led the round, with existing inves...
21.08.2026lab on a chip technology Market to Reach USD 21.36 Billion by 2030The global lab on a chip technology Market is projected to grow from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, registering a CAGR of 8.8% during the forecast period. Market growth is being driven by increasing demand for high-...
15.07.2026Biochips Market to Reach $21.36 Billion by 2030The global biochips market is projected to grow from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, at a CAGR of 8.8% during the forecast period. Market growth is fueled by increasing demand for faster, more accurate, and cost-effe...
14.07.2026Body Fluid Analysis Market to Reach $3.65 Billion by 2031The global body fluid analysis market is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031, at a CAGR of 6.9% during the forecast period. Market growth is primarily driven by the increasing global incidence of infe...
09.07.2026Global In Vitro Diagnostic (IVD) Products Market Share, Growth Drivers, Trends, Overall Sales and Demand Forecast To 2032The Global In Vitro Diagnostic (IVD) Products Market is witnessing remarkable growth as healthcare systems worldwide prioritize early disease detection, personalized treatment, and preventive care. In vitro diagnostic products have become a...
07.07.2026Molecular Diagnostics Market to Reach $30.74 Billion by 2030The global molecular diagnostics market is estimated at USD 19.48 billion in 2025 and is projected to reach USD 30.74 billion by 2030, growing at a CAGR of 9.6% during the forecast period. Market expansion is driven by increasing investment...
30.04.2026Moleculent: $20 Million Raised To Scale Functional Profiling Platform For Cell-Cell Communication ResearchMoleculent, a Stockholm-based life sciences technology company pioneering functional profiling to map cell-cell communication at scale in human tissue, has closed a $20 million financing round led by Rubicon Healthcare Partners, with partic...
18.12.2025Bringing rapid, lab-grade diagnostics to the pond side-
Show more

Reviews 0

Sign up to leave a review

Sign up Log In